Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced ( Nancy K Sweitzer  1 , Margarita Lopatin, Clyde W Yancy, Roger M Mills, Lynne W Stevenson Affiliations Expand Affiliation 1 University of Wisconsin, Madison, Wisconsin, USA. nks@medicine.wisc.edu PMID: 18394450 PMCID: PMC2390999 DOI: 10.1016/j.amjcard.2007.12.014 Free PMC article Item in Clipboard

Abstract

Heart failure (HF) with normal ejection fraction (EF) is an increasingly common presentation of acute decompensated HF. Differences between patients with HF and truly normal EF and those with mildly impaired EF have not been described. The Acute Decompensated Heart Failure Registry (ADHERE) contains information on >100,000 HF hospitalizations and may provide insight into this distinction. The ADHERE database was used to investigate differences between patients hospitalized with HF and severely (<25%), moderately (25% to 40%), and mildly (40% to 55%) decreased EF and those with normal EF (> or =55%). The group with normal EF was 69% women with a mean age of 74 years (p <0.0001 vs all other groups). Coronary artery disease was less frequent in the normal EF group, and hypertension played a larger role. Patients with EF > or =55% had increased pulse pressure, suggesting a role for arterial stiffening. Treatment differed by EF. Creatinine increased > or =0.5 mg/dl more often in the group with HF and normal EF than in the group with HF and severely decreased EF. In-hospital mortality and length of stay in the intensive care unit varied inversely with EF; overall length of stay was similar. In conclusion, patients with HF and normal EF are more likely to be women, have a history of high pulse pressure hypertension, less coronary artery disease, and a lower risk of inpatient death but a higher likelihood of deterioration in renal function during hospitalization. These observations may be important considerations in the design of future clinical trials.

Figures

Figure 1

A. Prevalence of a history of hypertension and history of coronary artery disease stratified by ejection fraction (EF) in the ADHERE population. B. Heart failure etiology was identified in the minority of cases in the ADHERE registry. Shown is attribution of heart failure etiology to hypertension or ischemic heart disease in patients in whom an etiology was identified. * = p

Figure 2

Use of intravenous medications to treat heart failure in the ADHERE populations stratified by ejection fraction. Diuretic use was high in all groups, but slightly greater in the two higher EF groups than in the two lower EF groups. Both inotropic and IV vasodilator medications were used significantly less often in the group with EF ≥ 55% than in all other groups. * = p